First smart connected insulin pens made available on NHS
March 2, 2022Research and Development
Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment
March 2, 2022Research and Development
The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
HPV vaccines could mean only one smear test a lifetime
March 2, 2022Research and Development
A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
FDA share new trial guidelines to further cancer therapy development
March 2, 2022Research and Development
The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
Moderna faces lawsuit over COVID-19 vaccine
March 1, 2022Manufacturing and Production
Moderna has been accused of ‘hijacking’ technology from two smaller biotech firms – Arbutus Biopharma and Genevant Sciences – to …
ELUNATE receives commercial approval in Macau
March 1, 2022Manufacturing and Production
HUTCHMED has received approval to market fruquintinib (ELUNATE in China), a selective and potent oral inhibitor of vascular endothelial growth …
FDA approves CAR-T therapy for multiple myeloma
March 1, 2022Manufacturing and Production
The FDA gas approved a therapy developed by J&J and its partner Legend Biotech, to treat relapsed or refractory multiple …
First oral diabetes treatment approved in Europe for use during pregnancy
March 1, 2022Manufacturing and Production
Merck has announced an extension to the label for metformin products in the EU – glucophage (metformin hydrochloride immediate release), …
Potential breakthrough trial for rare disease Hunter syndrome
February 28, 2022Sales and Marketing
Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the debilitating, life-limiting, rare disease mucopolysaccharidosis …
Phase III data show Dupixent reduced itch in chronic spontaneous urticaria patients
February 28, 2022Sales and Marketing
Results from a Phase III trial have revealed that adding Dupixent (dupilumab) to standard-of-care antihistamines significanty reduced itch and hives …
Urgent need to address mental health crisis among kidney patients
February 28, 2022Sales and Marketing
Kidney Research UK has released their findings from a survey of 1,000 kidney disease patients in the UK, revealing the …
Kapruvia receives positive CHMP opinion for pruritus in hemodialysis patients
February 28, 2022Sales and Marketing
The CHMP has approved Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in hemodialysis patients. …
Study reveals potential genetic determinants of unexplained child deaths
February 25, 2022Medical Communications
Various genetic determinants may cause a predisposition to Sudden Unexpected Death in Paediatrics (SUPD), which encompasses syndromes such as Sudden …
NICE draft guidance recommends tucatinib for advanced breast cancer
February 25, 2022Medical Communications
Roughly 400 people with advanced breast cancer are set to benefit from a new treatment, following the NICE publication of …
CHMP recommends QUVIVIQ in Europe as a new treatment for adult insomnia patients
February 25, 2022Medical Communications
The CHMP has adopted a positive opinion for the use of QUVIVIQ for the treatment of adult patients with insomnia. …
Plant-based COVID-19 vaccine approved
February 25, 2022Medical Communications
Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …
South Korea approves Pfizer vaccine for children aged 5-11
February 24, 2022Business Services
South Korea’s drug safety agency on authorised the use of Pfizer’s COVID-19 vaccine on 23 February, for children aged between …
CDC: some should wait longer for second COVID-19 vaccination
February 24, 2022Business Services
The CDC updated its vaccine guidance for COVID-19, recommending that some American over the age of 12 who have received …
New sickle cell treatment administered to first patients in England
February 24, 2022Business Services
Sickle cell patients have now begun receiving the first new treatment for the blood disorder in over 20 years. The …
NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients
February 24, 2022Business Services
NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
